Portfolio
1
companies
Oppenheimer led the Series C financing, which will support US expansion and the development of new diagnostic tools.
"The second Series C second close further supports deployment, development and validation of our platform-based product portfolio targeted for clinical research and clinical use,"
The medtech firm has raised $36m in a round led by Oppenheimer Holdings to accelerate its product pipeline and scale American operations.
"We are excited to have Oppenheimer and British Patient Capital join our mission to create safer and more accurate imaging technologies that will help clinicians shorten patients' diagnostic and treatment journeys,"
